| BRISTOL MYERS SQUIBB CO |
EVP, Chief Research Officer |
Market Share Units |
23,431 |
$1,241,609 |
$52.99 |
10 Mar 2025 |
Direct |
| BRISTOL MYERS SQUIBB CO |
EVP, Chief Research Officer |
Common Stock, $0.10 par value |
15,839 |
$999,599 |
$63.11 |
10 Mar 2025 |
Direct |
| BRISTOL MYERS SQUIBB CO |
EVP, Chief Research Officer |
Common Stock, $0.10 par value |
11,315 |
$608,634 |
$53.79 |
10 Mar 2024 |
Direct |
| BRISTOL MYERS SQUIBB CO |
EVP, Chief Research Officer |
Common Stock, $0.10 par value |
2,095 |
$132,225 |
$63.11 |
10 Mar 2025 |
BMS Savings and Investment Program |
| BRISTOL MYERS SQUIBB CO |
EVP, Chief Research Officer |
Common Stock, $0.10 par value |
1,657 |
$89,122 |
$53.79 |
10 Mar 2024 |
BMS Savings and Investment Program |
| BRISTOL MYERS SQUIBB CO |
EVP, Chief Research Officer |
Common Stock, $0.10 par value |
200 |
$12,622 |
$63.11 |
10 Mar 2025 |
Family Trust |
| BRISTOL MYERS SQUIBB CO |
EVP, Chief Research Officer |
Common Stock, $0.10 par value |
200 |
$10,758 |
$53.79 |
10 Mar 2024 |
Family Trust |
| BRISTOL MYERS SQUIBB CO |
EVP, Chief Research Officer |
Performance Shares |
35,146 |
|
|
10 Mar 2025 |
Direct |
| Translate Bio, Inc. |
Director |
Stock Option (right to buy) |
0 |
|
|
14 Sep 2021 |
Direct |